Real-world study of the concomitant use of biphasic insulin as part 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes

CONCLUSIONS: Combining BIAsp 30 + GLP-1RA provides glycaemic control with no significant difference to that of propensity score-matched people receiving basal insulin+GLP-1RA, with no increase in hypoglycaemia risk or weight gain.PMID:38088483 | DOI:10.1111/dme.15267

Source: Molecular Medicine - December 13, 2023 Category: Molecular Biology Authors: Melanie Davies Amra Ciric Alibegovic Gayathri Anil Uffe Christian Braae Anders Boeck Jensen Rikke Baastrup Nordsborg Source Type: research